An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
-
HLA-C
Class I Human Leukocyte Antigens (HLA-C ) are heterodimeric (heavy chain + β2m) surface molecules that bind small peptide antigens and engage T lymphocytes and NK cells expressing the T cell receptor and Killer Immunoglobulin- like Receptors (KIR).
Updated | 21/07/2011 10:10
News
-
Article in Oncogene, on August 8, 2011
Updated | 08/11/2011 17:05 -
Mediapharma on Tg3 Abruzzo
MediaPharma on TG3 Abruzzo "Il Settimanale", October 29, 2011
Updated | 08/11/2011 10:10 -
MediaPharma wins the semi-final of the European Venture Contest in Turin!
Updated | 13/12/2010 11:11 -
MediaPharma on Tg Leonardo
RAI TG Leonardo interviews Prof. S. Iacobelli, Founder and President of MediaPharma
Updated | 13/12/2010 11:11 -
MediaPharma has established the Scientific Advisory Board
Updated | 27/04/2010 16:04
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
